ETHK LABS INC.

Huajian Medical opened lower and closed flat at HKD 0.630. The stock briefly rose to HKD 0.640 in the morning session on news flow, then hit an intraday high of HKD 0.690 in the afternoon but rapidly gave back all gains, finishing unchanged. The company had issued a profit warning, projecting 2025 net profit of up to RMB 42.2 million, down 86.6% year-over-year, with no dividend declared. EPS for both Q3 and Q4 2025 were negative HKD 0.0014, and operating revenue fell 15.44% and 10.37% year-over-year, respectively. The stock is down 95.1% from its 52-week high of HKD 12.86 and has lost 74.8% year-to-date, trading below its 20-day (HKD 0.665) and 60-day (HKD 0.843) moving averages. Despite the fundamental weakness, short-term speculative capital drove a 9.5% intraday swing following the company's rebranding and proposed charter amendments.